[HTML][HTML] Current efforts and trends in the treatment of NASH
Of all the aspects of non-alcoholic fatty liver disease (NAFLD), the slowest advances have
occurred in the therapeutic field. Thirty-five years after its formal description and after 15 …
occurred in the therapeutic field. Thirty-five years after its formal description and after 15 …
Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease which affects≈
25% of the adult population worldwide, placing a tremendous burden on human health. The …
25% of the adult population worldwide, placing a tremendous burden on human health. The …
[HTML][HTML] Effect of aerobic and resistance exercise training on liver enzymes and hepatic fat in Iranian men with nonalcoholic fatty liver disease
A Shamsoddini, V Sobhani, MEG Chehreh… - Hepatitis …, 2015 - ncbi.nlm.nih.gov
Background: Nonalcoholic fatty liver disease (NAFLD) has different prevalence rates in
various parts of the world and is a risk factor for diabetes and cardiovascular disease that …
various parts of the world and is a risk factor for diabetes and cardiovascular disease that …
[HTML][HTML] Exercise induces tissue-specific adaptations to enhance cardiometabolic health
SP Ashcroft, B Stocks, B Egan, JR Zierath - Cell metabolism, 2024 - cell.com
The risk associated with multiple cancers, cardiovascular disease, diabetes, and all-cause
mortality is decreased in individuals who meet the current recommendations for physical …
mortality is decreased in individuals who meet the current recommendations for physical …
[PDF][PDF] Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized …
E Bacchi, C Negri, G Targher, N Faccioli, M Lanza… - …, 2013 - Wiley Online Library
Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty
liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no …
liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no …
[HTML][HTML] Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …
[HTML][HTML] Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial
Background & Aims Pharmacologic treatments for nonalcoholic steatohepatitis (NASH) are
limited. Lifestyle interventions are believed to be effective in reducing features of NASH …
limited. Lifestyle interventions are believed to be effective in reducing features of NASH …
[HTML][HTML] Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: A position statement from exercise and sport science Australia
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …
Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat—A systematic review …
F Battista, A Ermolao, MA van Baak… - Obesity …, 2021 - Wiley Online Library
This systematic review examined the impact of exercise intervention programs on selected
cardiometabolic health indicators in adults with overweight or obesity. Three electronic …
cardiometabolic health indicators in adults with overweight or obesity. Three electronic …
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial
Background & Aims Healthy lifestyle is the most important management of non-alcoholic
fatty liver disease (NAFLD). This study aimed at assessing the efficacy of a community …
fatty liver disease (NAFLD). This study aimed at assessing the efficacy of a community …